3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
30
Central Nervous System Neoplasms
18
Rectal Neoplasms
15
Colorectal Neoplasms
15
Lung Neoplasms
13
Colonic Neoplasms
11
Carcinoma, Non-Small-Cell Lung
11
Stomach Neoplasms
9
Pancreatic Neoplasms
9
Glioblastoma
9
Gliosarcoma
7
Neoplasm Metastasis
6
Esophageal Neoplasms
6
Brain Neoplasms
6
Adenocarcinoma Of Esophagus
6
Carcinoma, Intraductal, Noninfiltrating
5
Breast Neoplasms, Male
5
Breast Carcinoma In Situ
5
Squamous Cell Carcinoma of Head and Neck
4
Sarcoma
4
Mesothelioma, Malignant
4
Kidney Neoplasms
4
Head and Neck Neoplasms
4
Carcinoma, Renal Cell
4
Astrocytoma
4
Uterine Cervical Neoplasms
3
Urinary Bladder Neoplasms
3
Solitary Fibrous Tumor, Pleural
3
Prostatic Neoplasms
3
Ovarian Neoplasms
3
Interventions
Paclitaxel
12
Cisplatin
11
Hyperthermic Intraperitoneal Chemotherapy
10
Cytoreduction Surgical Procedures
9
Oxaliplatin
8
Fluorouracil
7
Mitomycin
6
Carboplatin
5
Leucovorin
4
Bevacizumab
4
catumaxomab
3
Doxorubicin
3
Docetaxel
3
sodium thiosulfate
2
Indocyanine Green
2
Drug Therapy
2
Cetuximab
2
volociximab
1
vandetanib
1
relacorilant
1
pasireotide
1
nilotinib
1
farletuzumab
1
epothilone B
1
enzastaurin
1
birinapant
1
alvimopan
1
Surgical Procedures, Operative
1
Saline Waters
1
Platinum
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Peritoneal Neoplasms
×
Chemotherapy, Adjuvant
×
Clear all
NCT00766142
2025-08-29
COCHISE
Institut Bergonié
Phase 2
Terminated
18 enrolled
9 charts